Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Expansion Outlook: What Revenue Opportunities Are Ahead?#_x000D_
The artificial intelligence (AI) in in vitro diagnostics (IVD) market has experienced rapid expansion over recent years. It is projected to expand from $3.04 billion in 2025 to $3.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.4%. This historical growth can be linked to several factors, including an increased need for precise diagnostics, the expansion of laboratory infrastructure, a higher incidence of chronic diseases, the integration of digital diagnostic tools, and progress in biomarker research._x000D_
_x000D_
The artificial intelligence (AI) in in vitro diagnostics (IVD) market is anticipated to undergo significant expansion in the coming years. It is projected to increase to $7.01 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 18.1%. This projected growth is driven by factors such as the expansion of cloud-based diagnostic platforms, the integration of AI with genomics, the development of point-of-care AI diagnostics, increasing investments in personalized medicine, and a heightened demand for rapid and cost-effective testing. Significant trends expected during this forecast period include AI-enabled laboratory automation, predictive disease diagnostics, data-driven test interpretation, cloud-based diagnostic platforms, and personalized patient profiling._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Opportunity Drivers: What’s Unlocking New Revenue Potential?#_x000D_
The surging demand for personalized medicine is poised to fuel the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market moving forward. Personalized medicine is a healthcare framework that customizes prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. The prevalence of personalized medicine is growing as progress in genomic data and sequencing technologies allows for more accurate, targeted, and effective treatments tailored to individual patients. Artificial intelligence (AI) in in vitro diagnostics (IVD) supports personalized medicine by analyzing complex diagnostic data to pinpoint patient-specific disease patterns, facilitating precise, timely, and customized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also included seven cancer drugs and three for other diseases and conditions. Therefore, the escalating demand for personalized medicine is stimulating the growth of the artificial intelligence (AI) in in vitro diagnostics (IVD) market._x000D_
_x000D_
#Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Segment Landscape: Which Areas Lead Development?#_x000D_
The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented – _x000D_
_x000D_
1) By Component: Software, Hardware, Services_x000D_
2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning_x000D_
3) By Deployment Model: Cloud-Based, On-Premise, Hybrid_x000D_
4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine_x000D_
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers_x000D_
_x000D_
Subsegments:_x000D_
1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems_x000D_
2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices_x000D_
3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education_x000D_
_x000D_
#Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Innovation Trends Shaping Future Development#_x000D_
Leading companies in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are concentrating on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms, to improve diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform refers to an AI system for in vitro diagnostics that complies with EU regulatory standards and offers clear, auditable, and understandable decision-making. For example, in May 2025, Diagnostics.ai, a UK-based diagnostic testing company, introduced PCR.AI, an intelligent solution designed to accelerate and enhance PCR diagnostics. This system automates and speeds up the interpretation of real-time PCR diagnostics with over 99.9% accuracy. It provides transparency by clearly demonstrating how each result is obtained, thereby ensuring regulatory compliance and strengthening clinical trust. This significantly boosts laboratory efficiency, minimizes errors, and facilitates smooth regulatory adherence for molecular diagnostics._x000D_
_x000D_
#Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Leading Companies And Competitive Benchmarking#_x000D_
Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj _x000D_
_x000D_
#View The Full Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report:#_x000D_
_x000D_
#Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Largest Region By Revenue And Market Share#_x000D_
North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
